Literature DB >> 8874220

Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein.

K Tenscher1, B Metzner, E Schöpf, J Norgauer, W Czech.   

Abstract

The novel human CC-chemokine Eotaxin is a potent and selective chemotaxin for eosinophils. Here, the biological activities and the activation profile of Eotaxin were further characterized and compared with those of other eosinophil chemotaxins such as complement fragment C5a (C5a), platelet-activating factor (PAF), and RANTES in human eosinophils. Eotaxin stimulated the production of reactive oxygen metabolites as shown by lucigenin-dependent chemiluminescence and superoxide dismutase-inhibitable cytochrome C reduction. Furthermore, Eotaxin induced upregulation of the integrin CD11b. In addition, fluorescence measurements with Fura-2-labeled eosinophils in the presence of EGTA indicated Ca(2+)-mobilization from intracellular stores by Eotaxin. Flow cytometric studies showed rapid and translent actin polymerization on stimulation with Eotaxin. At optimal concentrations, the changes induced by Eotaxin were comparable with those obtained by C5a, PAF, and RANTES. Call responses elicited by Eotaxin were inhibited by pertussis toxin, indicating coupling of its putative receptor to heterotrimeric guanine nucleotide-binding proteins. These results indicate that Eotaxin is a strong activator of eosinophils with biological activity comparable with those of the eosinophil chemotaxins C5a, PAF, and RANTES. These findings point to a role of Eotaxin in the pathogenesis of eosinophilic inflammation as a chemotaxin as well as an activator of proinflammatory effector functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874220

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Oxidant stress in asthma.

Authors:  R Dworski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Eotaxin expression in Sephadex-induced lung injury in rats.

Authors:  R F Guo; P A Ward; J A Jordan; M Huber-Lang; R L Warner; M M Shi
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

4.  The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow.

Authors:  J Kitayama; C R Mackay; P D Ponath; T A Springer
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

5.  Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling.

Authors:  Patricia C Fulkerson; Christine A Fischetti; Marc E Rothenberg
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

6.  CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism.

Authors:  Patricia C Fulkerson; Hongyan Zhu; David A Williams; Nives Zimmermann; Marc E Rothenberg
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

7.  Human eotaxin induces eosinophil extravasation through rat mesenteric venules: role of alpha4 integrins and vascular cell adhesion molecule-1.

Authors:  K Nagai; S Larkin; A Hartnell; K Larbi; M Razi Aghakhani; C Windley; D Davies; R R Lobb; T J Williams; S Nourshargh
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

8.  The Effect of Helminths on Granulocyte Activation: A Cluster-Randomized Placebo-Controlled Trial in Indonesia.

Authors:  Karin de Ruiter; Dicky L Tahapary; Erliyani Sartono; Thomas B Nutman; Johannes W A Smit; Leo Koenderman; Taniawati Supali; Maria Yazdanbakhsh
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

Review 9.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 10.  Targeting eosinophils in allergy, inflammation and beyond.

Authors:  Patricia C Fulkerson; Marc E Rothenberg
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.